The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Streptococcal Toxic-Shock Syndrome: Spectrum of Disease, Pathogenesis, and New Concepts in Treatment
Open accessAbstract
Since the 1980s there has been a marked increase in the recognition and reporting of highly invasive group A streptococcal infections with or without necrotizing fasciitis associated with shock and organ failure. Such dramatic cases have been defined as streptococcal toxic-shock syndrome. Strains of group A streptococci isolated from patients with invasive disease have been predominantly M types 1 and 3 that produce pyrogenic exotoxin A or B or both. In this paper, the clinical and demographic features of streptococcal bacteremia, myositis, and necrotizing fasciitis are presented and compared to those of streptococcal toxic-shock syndrome. Current concepts in the pathogenesis of invasive streptococcal infection are also presented, with emphasis on the interaction between group A Streptococcus virulence factors and host defense mechanisms. Finally, new concepts in the treatment of streptococcal toxic-shock syndrome are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stevens, D. L., Tanner, M. H., Winship, J., Swarts, R., Ries, K. M., Schlievert, P. M., & Kaplan, E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198907063210101 · Cited by 1,216
Self-citationCurrent Knowledge of Type-Specific M Antigens of Group A Streptococci
Lancefield, R. C. (1962) · The Journal of Immunology · doi:10.4049/jimmunol.89.3.307 · Cited by 780
Invasive Group A Streptococcus Infections
Stevens, D. L. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.1.2 · Cited by 710
Self-citationHEMOLYTIC STREPTOCOCCUS GANGRENE
MELENEY, F. L. (1924) · Archives of Surgery · doi:10.1001/archsurg.1924.01120080083007 · Cited by 586
Stevens, D. L., Gibbons, A. E., Bergstrom, R., & Winn, V. (1988) · Journal of Infectious Diseases · doi:10.1093/infdis/158.1.23 · Cited by 473
Self-citationMusser, J. M., Hauser, A. R., Kim, M. H., Schlievert, P. M., Nelson, K., & Selander, R. K. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2668 · Cited by 421
Changing epidemiology of group A streptococcal infection in the USA
Schwartz, B., Facklam, R. J., & Breiman, R. F. (1990) · The Lancet · doi:10.1016/0140-6736(90)92777-f · Cited by 418
Johnson, D. R., Stevens, D. L., & Kaplan, E. L. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/166.2.374 · Cited by 366
Self-citationClonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s
Cleary, P. P., Schlievert, P. M., Handley, J. P., Kim, M. H., Hauser, A. R., Kaplan, E. L., & Wlazlo, A. (1992) · The Lancet · doi:10.1016/0140-6736(92)90339-5 · Cited by 321
Aspects of Pathogenesis of Serious Group A Streptococcal Infections in Sweden, 1988-1989
Holm, S. E., Norrby, A., Bergholm, A.-M., & Norgren, M. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/166.1.31 · Cited by 302
Experimental approach to the problem of treatment failure with penicillin
Eagle, H. (1952) · The American Journal of Medicine · doi:10.1016/0002-9343(52)90293-3 · Cited by 280
Fast, D. J., Schlievert, P. M., & Nelson, R. D. (1989) · Infection and Immunity · doi:10.1128/iai.57.1.291-294.1989 · Cited by 272
Kapur, V, Majesky, M. W., Li, L. L., Black, R. A., & Musser, J. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7676 · Cited by 256
Severe Invasive Group A Streptococcal Infections In Ontario, Canada: 1987-1991
Demers, B., Simor, A. E., Vellend, H., Schlievert, P. M., Byrne, S., Jamieson, F., Walmsley, S., & Low, D. E. (1993) · Clinical Infectious Diseases · doi:10.1093/clind/16.6.792 · Cited by 251
Intravenous Immunoglobulin Therapy for Toxic Shock Syndrome
Barry, W. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480240077038 · Cited by 248
Spontaneous, Nontraumatic Gangrene Due to Clostridium septicum
Stevens, D. L., Musher, D. M., Watson, D. A., Eddy, H., Hamill, R. J., Gyorkey, F., Rosen, H., & Mader, J. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.2.286 · Cited by 217
Self-citationStevens, D. L., Van, S., & Bryant, A. E. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.6.1401 · Cited by 211
Self-citationGemmell, C. G., Peterson, P. K., Schmeling, D., Kim, Y., Mathews, J., Wannamaker, L., & Quie, P. G. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110152 · Cited by 207
Hackett, S. P., & Stevens, D. L. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/165.5.879 · Cited by 191
Self-citationFAILURE OF PENICILLIN TO ERADICATE GROUP A STREPTOCOCCI DURING AN OUTBREAK OF PHARYNGITIS
Gastanaduy, A., Huwe, B., Kaplan, E., Mckay, C., & Wannamaker, L. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91832-2 · Cited by 174
Effect of antibiotics on toxin production and viability of Clostridium perfringens
Stevens, D. L., Maier, K. A., & Mitten, J. E. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.2.213 · Cited by 171
Self-citationAntibiotic Effects on Bacterial Viability, Toxin Production, and Host Response
Stevens, D. L., Bryant, A. E., & Hackett, S. P. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.supplement_2.s154 · Cited by 154
Self-citationAdams, E. M. (1985) · Archives of Internal Medicine · doi:10.1001/archinte.145.6.1020 · Cited by 147
Kim, K. S., & Kaplan, E. L. (1985) · The Journal of Pediatrics · doi:10.1016/s0022-3476(85)80392-9 · Cited by 141
Superantigenic properties of the group A streptococcal exotoxin SpeF (MF)
Norrby‐Teglund, A., Newton, D. W., Kotb, M., Holm, S. E., & Norgren, M. (1994) · Infection and Immunity · doi:10.1128/iai.62.12.5227-5233.1994 · Cited by 125
Impetigo Contagiosa: Suppurative and Non-Suppurative Complications
Dillon, H. C. (1968) · American journal of diseases of children · doi:10.1001/archpedi.1968.02100010532002 · Cited by 112
Hackett, S. P., & Stevens, D. L. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/168.1.232 · Cited by 111
Self-citationRheumatic fever‐associated B cell alloantigens as identified by monoclonal antibodies
Zabriskie, J. B., Lavenchy, D., Williams, R. C., Fu, S. M., Yeadon, C. A., Fotino, M., & Braun, D. G. (1985) · Arthritis & Rheumatism · doi:10.1002/art.1780280912 · Cited by 110
Müller‐Alouf, H., ALOUF, J. E., Gerlach, D., Ozegowski, J., Fitting, C., & Cavaillon, J. (1994) · Infection and Immunity · doi:10.1128/iai.62.11.4915-4921.1994 · Cited by 104
Brook, I. (1985) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-198509000-00010 · Cited by 100
Streptococcus pyogenes and the Toxic Shock Syndrome
Hřı́balová, V. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-5-772_2 · Cited by 61
Korpics, M. (1986) · Journal of Emergency Medicine · doi:10.1016/0736-4679(86)90122-8 · Cited by 59
Yoder, E., Mendez, J., & Khatib, R. (1987) · Clinical Infectious Diseases · doi:10.1093/clinids/9.2.382 · Cited by 51
Braunstein, H. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/13.1.8 · Cited by 47
Cited by
Complete genome sequence of an M1 strain of Streptococcus pyogenes
Ferretti, J. J., McShan, W. M., Ajdic, D., Savic, D. J., Savic, G., Lyon, K., Primeaux, C., Sezate, S., Suvorov, A. N., Kenton, S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071559398 · Cited by 936
Toxic Shock Syndrome and Bacterial Superantigens: An Update
McCormick, J. K., Yarwood, J. M., & Schlievert, P. M. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.77 · Cited by 785
IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G
von Pawel-Rammingen, U. (2002) · The EMBO Journal · doi:10.1093/emboj/21.7.1607 · Cited by 473
Hakkarainen, T. W., Kopari, N. M., Pham, T. N., & Evans, H. L. (2014) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2014.06.001 · Cited by 460
Epidemiology of Severe Streptococcus pyogenes Disease in Europe
Lamagni, T. L., Darenberg, J., Luca-Harari, B., Siljander, T., Efstratiou, A., Henriques-Normark, B., Vuopio-Varkila, J., Bouvet, A., Creti, R., Ekelund, K., et al. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00422-08 · Cited by 410
Metadata
- Authors
- Stevens, D. L.
- Venue
- Emerging Infectious Diseases
- Published
- 1995-06
- Volume
- 1
- Issue
- 3
- Pages
- 69-78
- ISSN
- 1080-6040 (ISSN-L)
- 1080-6059
- OpenAlex
- W2147547119
- Cited by
- 471
- References
- 34
- FWCI
- 25.22
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.